Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1996 Sep;59(3):644–652.

Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test.

D E Grice 1, J F Leckman 1, D L Pauls 1, R Kurlan 1, K K Kidd 1, A J Pakstis 1, F M Chang 1, J D Buxbaum 1, D J Cohen 1, J Gelernter 1
PMCID: PMC1914894  PMID: 8751866

Abstract

Dopaminergic abnormalities are implicated in the pathogenesis of Tourette syndrome (TS) and chronic multiple tics. We used the transmission-disequilibrium test (TDT) method to test for linkage disequilibrium between a specific allele (the seven-repeat allele (DRD4*7R) of the exon 3 VNTR polymorphic site) at the D4 dopamine receptor locus (DRD4) and expression of chronic multiple tics and TS. This particular allele had been shown in functional studies to have different binding properties compared with the other common alleles in this DRD4 polymorphic system. We studied 64 family trios (consisting of an affected person and two parents, at least one heterozygous for DRD4*7R), including 12 nuclear family trios and 52 trios from four large TS kindreds. The DRD4*7R allele was transmitted significantly more frequently than expected (chi 2 TDT ranging from 8.47 [P < .004] to 10.80 [P = .001], depending on breadth of disease definition and inclusion or exclusion of inferred genotypes). Confirmation of this finding will depend on either replication in other samples or the identification of a transmitted functional mutation within this sample.

Full text

PDF
644

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H. H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem. 1995 Sep;65(3):1157–1165. doi: 10.1046/j.1471-4159.1995.65031157.x. [DOI] [PubMed] [Google Scholar]
  2. Asghari V., Schoots O., van Kats S., Ohara K., Jovanovic V., Guan H. C., Bunzow J. R., Petronis A., Van Tol H. H. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol. 1994 Aug;46(2):364–373. [PubMed] [Google Scholar]
  3. Benjamin J., Li L., Patterson C., Greenberg B. D., Murphy D. L., Hamer D. H. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet. 1996 Jan;12(1):81–84. doi: 10.1038/ng0196-81. [DOI] [PubMed] [Google Scholar]
  4. Catalano M., Nobile M., Novelli E., Nöthen M. M., Smeraldi E. Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients. Biol Psychiatry. 1993 Oct 1;34(7):459–464. doi: 10.1016/0006-3223(93)90236-7. [DOI] [PubMed] [Google Scholar]
  5. Chang F. M., Kidd J. R., Livak K. J., Pakstis A. J., Kidd K. K. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet. 1996 Jul;98(1):91–101. doi: 10.1007/s004390050166. [DOI] [PubMed] [Google Scholar]
  6. Cohen D. J., Leckman J. F. Developmental psychopathology and neurobiology of Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1994 Jan;33(1):2–15. doi: 10.1097/00004583-199401000-00002. [DOI] [PubMed] [Google Scholar]
  7. Comings D. E., Comings B. G. A controlled study of Tourette syndrome. I. Attention-deficit disorder, learning disorders, and school problems. Am J Hum Genet. 1987 Nov;41(5):701–741. [PMC free article] [PubMed] [Google Scholar]
  8. Curtis D., Sham P. C. A note on the application of the transmission disequilibrium test when a parent is missing. Am J Hum Genet. 1995 Mar;56(3):811–812. [PMC free article] [PubMed] [Google Scholar]
  9. Ebstein R. P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennett E. R., Nemanov L., Katz M., Belmaker R. H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet. 1996 Jan;12(1):78–80. doi: 10.1038/ng0196-78. [DOI] [PubMed] [Google Scholar]
  10. Erenberg G., Cruse R. P., Rothner A. D. Gilles de la Tourette's syndrome: effects of stimulant drugs. Neurology. 1985 Sep;35(9):1346–1348. doi: 10.1212/wnl.35.9.1346. [DOI] [PubMed] [Google Scholar]
  11. Ewens W. J., Spielman R. S. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet. 1995 Aug;57(2):455–464. [PMC free article] [PubMed] [Google Scholar]
  12. Feinberg M., Carroll B. J. Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry. 1979 Aug;36(9):979–985. doi: 10.1001/archpsyc.1979.01780090065007. [DOI] [PubMed] [Google Scholar]
  13. Gelernter J., Goldman D., Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. JAMA. 1993 Apr 7;269(13):1673–1677. [PubMed] [Google Scholar]
  14. Gelernter J., Kennedy J. L., Grandy D. K., Zhou Q. Y., Civelli O., Pauls D. L., Pakstis A., Kurlan R., Sunahara R. K., Niznik H. B. Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor. Am J Psychiatry. 1993 Mar;150(3):449–453. doi: 10.1176/ajp.150.3.449. [DOI] [PubMed] [Google Scholar]
  15. Gelernter J., Kennedy J. L., van Tol H. H., Civelli O., Kidd K. K. The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics. 1992 May;13(1):208–210. doi: 10.1016/0888-7543(92)90222-e. [DOI] [PubMed] [Google Scholar]
  16. Gelernter J., Pakstis A. J., Pauls D. L., Kurlan R., Gancher S. T., Civelli O., Grandy D., Kidd K. K. Gilles de la Tourette syndrome is not linked to D2-dopamine receptor. Arch Gen Psychiatry. 1990 Nov;47(11):1073–1077. doi: 10.1001/archpsyc.1990.01810230089014. [DOI] [PubMed] [Google Scholar]
  17. Gelernter J., Vandenbergh D., Kruger S. D., Pauls D. L., Kurlan R., Pakstis A. J., Kidd K. K., Uhl G. The dopamine transporter protein gene (SLC6A3): primary linkage mapping and linkage studies in Tourette syndrome. Genomics. 1995 Dec 10;30(3):459–463. doi: 10.1006/geno.1995.1265. [DOI] [PubMed] [Google Scholar]
  18. Goate A., Chartier-Harlin M. C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991 Feb 21;349(6311):704–706. doi: 10.1038/349704a0. [DOI] [PubMed] [Google Scholar]
  19. Hasstedt S. J., Leppert M., Filloux F., van de Wetering B. J., McMahon W. M. Intermediate inheritance of Tourette syndrome, assuming assortative mating. Am J Hum Genet. 1995 Sep;57(3):682–689. [PMC free article] [PubMed] [Google Scholar]
  20. Higgins M. J., Smilinich N. J., Sait S., Koenig A., Pongratz J., Gessler M., Richard C. W., 3rd, James M. R., Sanford J. P., Kim B. W. An ordered NotI fragment map of human chromosome band 11p15. Genomics. 1994 Sep 1;23(1):211–222. doi: 10.1006/geno.1994.1479. [DOI] [PubMed] [Google Scholar]
  21. Jankovic J., Glaze D. G., Frost J. D., Jr Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome. Neurology. 1984 May;34(5):688–692. doi: 10.1212/wnl.34.5.688. [DOI] [PubMed] [Google Scholar]
  22. Kidd K. K. Associations of disease with genetic markers: déjà vu all over again. Am J Med Genet. 1993 Jul 15;48(2):71–73. doi: 10.1002/ajmg.1320480202. [DOI] [PubMed] [Google Scholar]
  23. Kidd K. K., Prusoff B. A., Cohen D. J. Familial pattern of Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1980 Dec;37(12):1336–1339. doi: 10.1001/archpsyc.1980.01780250022001. [DOI] [PubMed] [Google Scholar]
  24. Klawans H. L., Nausieda P. A., Goetz C. C., Tanner C. M., Weiner W. J. Tourette-like symptoms following chronic neuroleptic therapy. Adv Neurol. 1982;35:415–418. [PubMed] [Google Scholar]
  25. Kurlan R., Behr J., Medved L., Shoulson I., Pauls D., Kidd J. R., Kidd K. K. Familial Tourette's syndrome: report of a large pedigree and potential for linkage analysis. Neurology. 1986 Jun;36(6):772–776. doi: 10.1212/wnl.36.6.772. [DOI] [PubMed] [Google Scholar]
  26. Kurlan R. Tourette's syndrome: current concepts. Neurology. 1989 Dec;39(12):1625–1630. doi: 10.1212/wnl.39.12.1625. [DOI] [PubMed] [Google Scholar]
  27. Lahiri D. K., Nurnberger J. I., Jr A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991 Oct 11;19(19):5444–5444. doi: 10.1093/nar/19.19.5444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Leckman J. F., Goodman W. K., Anderson G. M., Riddle M. A., Chappell P. B., McSwiggan-Hardin M. T., McDougle C. J., Scahill L. D., Ort S. I., Pauls D. L. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology. 1995 Feb;12(1):73–86. doi: 10.1038/sj.npp.1380241. [DOI] [PubMed] [Google Scholar]
  29. Lichter J. B., Barr C. L., Kennedy J. L., Van Tol H. H., Kidd K. K., Livak K. J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet. 1993 Jun;2(6):767–773. doi: 10.1093/hmg/2.6.767. [DOI] [PubMed] [Google Scholar]
  30. Lombroso P. J., Mack G., Scahill L., King R. A., Leckman J. F. Exacerbation of Gilles de la Tourette's syndrome associated with thermal stress: a family study. Neurology. 1991 Dec;41(12):1984–1987. doi: 10.1212/wnl.41.12.1984. [DOI] [PubMed] [Google Scholar]
  31. Malison R. T., McDougle C. J., van Dyck C. H., Scahill L., Baldwin R. M., Seibyl J. P., Price L. H., Leckman J. F., Innis R. B. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry. 1995 Sep;152(9):1359–1361. doi: 10.1176/ajp.152.9.1359. [DOI] [PubMed] [Google Scholar]
  32. Meador-Woodruff J. H., Grandy D. K., Van Tol H. H., Damask S. P., Little K. Y., Civelli O., Watson S. J., Jr Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology. 1994 Jul;10(4):239–248. doi: 10.1038/npp.1994.27. [DOI] [PubMed] [Google Scholar]
  33. Nöthen M. M., Cichon S., Hemmer S., Hebebrand J., Remschmidt H., Lehmkuhl G., Poustka F., Schmidt M., Catalano M., Fimmers R. Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum Mol Genet. 1994 Dec;3(12):2207–2212. doi: 10.1093/hmg/3.12.2207. [DOI] [PubMed] [Google Scholar]
  34. Ott J. Complex traits on the map. Nature. 1996 Feb 29;379(6568):772–773. doi: 10.1038/379772a0. [DOI] [PubMed] [Google Scholar]
  35. Pakstis A. J., Heutink P., Pauls D. L., Kurlan R., van de Wetering B. J., Leckman J. F., Sandkuyl L. A., Kidd J. R., Breedveld G. J., Castiglione C. M. Progress in the search for genetic linkage with Tourette syndrome: an exclusion map covering more than 50% of the autosomal genome. Am J Hum Genet. 1991 Feb;48(2):281–294. [PMC free article] [PubMed] [Google Scholar]
  36. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993 Oct 14;365(6447):649–651. doi: 10.1038/365649a0. [DOI] [PubMed] [Google Scholar]
  37. Pauls D. L., Leckman J. F., Cohen D. J. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering. J Am Acad Child Adolesc Psychiatry. 1993 Sep;32(5):1044–1050. doi: 10.1097/00004583-199309000-00025. [DOI] [PubMed] [Google Scholar]
  38. Pauls D. L., Leckman J. F. The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission. N Engl J Med. 1986 Oct 16;315(16):993–997. doi: 10.1056/NEJM198610163151604. [DOI] [PubMed] [Google Scholar]
  39. Peterson B. S., Leckman J. F., Scahill L., Naftolin F., Keefe D., Charest N. J., Cohen D. J. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology. 1992 Nov;17(6):553–563. doi: 10.1016/0306-4530(92)90015-y. [DOI] [PubMed] [Google Scholar]
  40. Rao P. A., Pickar D., Gejman P. V., Ram A., Gershon E. S., Gelernter J. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch Gen Psychiatry. 1994 Nov;51(11):912–917. doi: 10.1001/archpsyc.1994.03950110072009. [DOI] [PubMed] [Google Scholar]
  41. Seeman P., Ulpian C., Chouinard G., Van Tol H. H., Dwosh H., Lieberman J. A., Siminovitch K., Liu I. S., Waye J., Voruganti P. Dopamine D4 receptor variant, D4GLYCINE194, in Africans, but not in Caucasians: no association with schizophrenia. Am J Med Genet. 1994 Dec 15;54(4):384–390. doi: 10.1002/ajmg.1320540419. [DOI] [PubMed] [Google Scholar]
  42. Shapiro E., Shapiro A. K., Fulop G., Hubbard M., Mandeli J., Nordlie J., Phillips R. A. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry. 1989 Aug;46(8):722–730. doi: 10.1001/archpsyc.1989.01810080052006. [DOI] [PubMed] [Google Scholar]
  43. Singer H. S., Hahn I. H., Moran T. H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol. 1991 Oct;30(4):558–562. doi: 10.1002/ana.410300408. [DOI] [PubMed] [Google Scholar]
  44. Spielman R. S., McGinnis R. E., Ewens W. J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993 Mar;52(3):506–516. [PMC free article] [PubMed] [Google Scholar]
  45. Sverd J., Gadow K. D., Paolicelli L. M. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):574–582. doi: 10.1097/00004583-198907000-00016. [DOI] [PubMed] [Google Scholar]
  46. Sweet R. D., Bruun R., Shapiro E., Shapiro A. K. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine. Arch Gen Psychiatry. 1974 Dec;31(6):857–861. doi: 10.1001/archpsyc.1974.01760180095012. [DOI] [PubMed] [Google Scholar]
  47. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet. 1995 Aug;57(2):487–498. [PMC free article] [PubMed] [Google Scholar]
  48. Van Tol H. H., Bunzow J. R., Guan H. C., Sunahara R. K., Seeman P., Niznik H. B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature. 1991 Apr 18;350(6319):610–614. doi: 10.1038/350610a0. [DOI] [PubMed] [Google Scholar]
  49. Van Tol H. H., Wu C. M., Guan H. C., Ohara K., Bunzow J. R., Civelli O., Kennedy J., Seeman P., Niznik H. B., Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature. 1992 Jul 9;358(6382):149–152. doi: 10.1038/358149a0. [DOI] [PubMed] [Google Scholar]
  50. Weeks D. E., Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet. 1988 Feb;42(2):315–326. [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES